- Home
- ALIT vs SYRE Comparison
ALIT vs SYRE Comparison
Compare ALIT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALIT
- SYRE
- Stock Information
- Founded
- ALIT 2017
- SYRE 2013
- Country
- ALIT United States
- SYRE United States
- Employees
- ALIT N/A
- SYRE N/A
- Industry
- ALIT Business Services
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- ALIT Consumer Discretionary
- SYRE Health Care
- Exchange
- ALIT Nasdaq
- SYRE Nasdaq
- Market Cap
- ALIT 1.1B
- SYRE 1.1B
- IPO Year
- ALIT N/A
- SYRE 2016
- Fundamental
- Price
- ALIT $2.25
- SYRE $28.97
- Analyst Decision
- ALIT Strong Buy
- SYRE Strong Buy
- Analyst Count
- ALIT 4
- SYRE 4
- Target Price
- ALIT $5.25
- SYRE $52.67
- AVG Volume (30 Days)
- ALIT 13.7M
- SYRE 656.3K
- Earning Date
- ALIT 11-05-2025
- SYRE 11-04-2025
- Dividend Yield
- ALIT 7.14%
- SYRE N/A
- EPS Growth
- ALIT N/A
- SYRE N/A
- EPS
- ALIT N/A
- SYRE N/A
- Revenue
- ALIT $2,289,000,000.00
- SYRE N/A
- Revenue This Year
- ALIT $0.51
- SYRE N/A
- Revenue Next Year
- ALIT $2.39
- SYRE N/A
- P/E Ratio
- ALIT N/A
- SYRE N/A
- Revenue Growth
- ALIT N/A
- SYRE N/A
- 52 Week Low
- ALIT $1.89
- SYRE $10.91
- 52 Week High
- ALIT $8.21
- SYRE $29.29
- Technical
- Relative Strength Index (RSI)
- ALIT 37.62
- SYRE 76.07
- Support Level
- ALIT $1.89
- SYRE $23.01
- Resistance Level
- ALIT $2.05
- SYRE $25.42
- Average True Range (ATR)
- ALIT 0.14
- SYRE 1.74
- MACD
- ALIT 0.01
- SYRE 0.33
- Stochastic Oscillator
- ALIT 52.21
- SYRE 97.66
About ALIT Alight Inc.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.